#Japan #Tokyo #Meiji #MI-2 #Yoghurt

Meiji Launches New Blueberry-flavored Yoghurt Drink

On October 13, 2026, Meiji Co., Ltd. is set to introduce a fresh addition to its successful line of functional yoghurt, focused on aiding individuals with elevated hemoglobin A1c levels. The new "Meiji Hemoglobin A1c Support Yoghurt Drink in Blueberry Flavor" is designed for those who are health-conscious yet want to maintain a delicious flavor in their daily diets.

Since its initial launch in October 2025, the Meiji Hemoglobin A1c Yoghurt has witnessed an impressive sales increase, reaching nearly double the projected figures, being reported at 1.9 times higher than the expected sales targets. With consumer interest peaking for products that support health management without compromise, Meiji responds with this vibrant blueberry option.

The New Product Features

Functional Ingredients

One of the standout aspects of the new blueberry yoghurt drink is the inclusion of MI-2 lactobacillus, a specifically studied strain shown to help lower hemoglobin A1c levels in healthy adults exhibiting higher Body Mass Index (BMI). This component makes it easier for customers to include this yoghurt drink in their routine, promoting a health-conscious lifestyle without sacrificing taste.

Sugar-free Delight

Mindful of sugar intake, this new yoghurt drink is produced without any added sugars. It provides a refreshing and light blueberry taste, making it an effortlessly enjoyable daily habit. The product is conveniently packaged in 112g servings, ensuring it's easily portable and ready for consumption at any moment.

Effective Blood Sugar Management

Hemoglobin A1c serves as an essential indicator for blood glucose management, reflecting the average blood sugar levels over the past two to three months. Its importance lies in showing longer-term changes, which is crucial for effective health management. As dietary habits continue to shift, products like the Meiji Blueberry Yoghurt Drink offer practical solutions for those monitoring their glucose levels.

Meiji has been dedicated to researching the MI-2 strain for over a decade, bringing forth a functional food that supports healthy blood sugar levels in a delicious format. The introduction of the Blueberry Yoghurt Drink aligns with their commitment to enhancing everyday health traditions among their customers.

Continued Success and Market Growth

The combination of functionality and flavor is expected to drive further interest in the Meiji Hemoglobin A1c Yoghurt series. Since its inception, consumers have shown high trial and repeat purchase rates, with the product quickly becoming a staple for health-conscious individuals. Given the recent feedback for a fruity flavor, the blueberry option aims to further cater to customer preferences while maintaining a focus on health.

Meiji's ambition doesn't stop here; with the launch of this new product, they aim to continue invigorating the yoghurt market and emphasize the incorporation of healthy habits into daily life. The new drink is priced at a suggested retail price of JPY 161, aligning with consumer expectations for both value and quality in health-related products.

As we move towards a more health-aware society, products such as this blueberry yoghurt drink represent a significant step towards integrating taste and health seamlessly into consumer diets. Meiji looks forward to making a positive impact on the health and well-being of individuals seeking to manage their hemoglobin A1c levels effectively through enjoyable dietary choices.